Novartis AG

Open: 104.78 Close: 105.2 Change: 0.42

Our AI found some flaws in Novartis AG Company Inc Stock.

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, NVS, Swiss, buy, company, deal, and the most common words in the summary are: novartis, stock, market, job, top, ag, news, . One of the sentences in the summary was: Novartis AG (NVS) stock is lower by -0.12% while the S&P …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG (NVS) stock is lower by -0.12% while the S&P 500 is higher by 0.32% as of 3:30 PM on Wednesday, Jul 19. Swiss drugmaker reported second-quarter earnings topped Wall Streets expectations.

Today's News

Novartis AG (NVS) stock is lower by -0.12% while the S&P 500 is higher by 0.32% as of 3:30 PM on Wednesday, Jul 19. The Swiss drugmaker reported second-quarter earnings topped Wall Streets expectations. Swiss biopharma giant Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.5 billion. Shares of Chinook stock rose 67% to $40.02 after it agreed to be bought by Novaris NVS, +0.28% for up to $3 billion. Novartis AG to report second-quarter 2023 results on Jul 18. Swiss pharma giant set to announce buyback of up to $15 billion in shares as it prepares to spin off its Sandoz generics unit. Novartis has acquired DTx Pharma for up to $1 billion, the companies said. The deal is designed to strengthen the buyers neuroscience pipeline and expand its capabilities in RNA therapeutics. Novartes agreed to pay $500 million upfront for DTx. Novartis AG buys Dtx Pharma Inc. for $1B in $2.5B deal. Roche, Beigene end $1 billion deal for ociperlimab. Novartis Ag is a general drug manufacturer company located in Switzerland. Novarti Ag is traded under the ticker NVS on the NYSE exchange. The company is currently +39.32% from its 52-week low of $74.09, and -2.22% from $105.56.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

This document will help you to evaluate Novartis AG without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, NVS, Swiss, buy, company, deal, and the most common words in the summary are: novartis, stock, market, job, top, ag, news, . One of the sentences in the summary was: Novartis AG (NVS) stock is lower by -0.12% while the S&P 500 is higher by 0.32% as of 3:30 PM on Wednesday, Jul 19. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #stock #market #job #top #ag #news.